Thanks very much, operator and good afternoon, everyone, and welcome to our third quarter 2024 results call. I'm Peter Slan, Chief Financial Officer and I'm joined on today's call by Mitch ...
Greetings, and welcome to the Panbela Therapeutics Third Quarter 2024EarningsCall. At this time ... General and administrative expenses were approximately $1.1 million in Q3 of 2024. This ...
2024. This release is available on the Investor Relations section of the company's website at www.boxlight.com. Hosting the call today are Dale Strang, Chief Executive Officer; and Greg Wiggins, ...
Some results have been hidden because they may be inaccessible to you